(0.04%) 5 208.75 points
(0.12%) 39 042 points
(-0.05%) 18 186 points
(-0.04%) $78.45
(-1.50%) $2.16
(-0.18%) $2 327.00
(-0.58%) $27.46
(0.24%) $967.20
(0.10%) $0.929
(0.31%) $10.86
(0.20%) $0.798
(-0.32%) $91.05
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 13.74%
-4.01% $ 0.941
Live Chart Being Loaded With Signals
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases...
Stats | |
---|---|
Volumen de hoy | 118 444 |
Volumen promedio | 101 306 |
Capitalización de mercado | 32.64M |
EPS | $0 ( 2024-03-21 ) |
Próxima fecha de ganancias | ( $-0.160 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.450 |
ATR14 | $0.00500 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Behner Peter | Buy | 16 185 | Common Stock |
2024-03-01 | Ryan Barbara | Buy | 18 685 | Common Stock |
2024-03-01 | Wiinberg Ulf | Buy | 15 790 | Common Stock |
2024-03-01 | Corvese Brian | Buy | 18 816 | Common Stock |
2024-01-16 | Van Dijk Marcus Antonius | Buy | 171 078 | Stock Option |
INSIDER POWER |
---|
-43.59 |
Last 97 transactions |
Buy: 6 422 397 | Sell: 29 448 104 |
Volumen Correlación
MiNK Therapeutics, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
MMAC | 0.859 |
EPSN | 0.847 |
CLFD | 0.834 |
NETE | 0.828 |
LYRA | 0.825 |
INPX | 0.812 |
DSGN | 0.808 |
NBIX | 0.808 |
AMRB | 0.804 |
REYN | 0.802 |
10 Correlaciones Más Negativas | |
---|---|
RMRM | -0.834 |
CPAA | -0.829 |
TIOAU | -0.826 |
SVAC | -0.818 |
MTSL | -0.817 |
CVCO | -0.814 |
THCP | -0.813 |
AEAE | -0.813 |
PAIC | -0.813 |
TIOA | -0.81 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MiNK Therapeutics, Inc. Correlación - Moneda/Commodity
MiNK Therapeutics, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-204 617 (0.00 %) |
EPS: | $-0.650 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-204 617 (0.00 %) |
EPS: | $-0.650 |
FY | 2022 |
Ingresos: | $2.70B |
Beneficio Bruto: | $-28.24B (-1 044.26 %) |
EPS: | $-0.740 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.160 |
Financial Reports:
No articles found.
MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico